EMA Needs To Release DHT Guidance Now
As digital health technologies (DHTs) increasingly permeate the landscape of clinical trials, the European Medicines Agency (EMA) faces mounting...
As digital health technologies (DHTs) increasingly permeate the landscape of clinical trials, the European Medicines Agency (EMA) faces mounting...
Integrating Digital Health Technologies (DHTs) in drug development is revolutionizing clinical trials, especially with the rise of decentralized clinical...
This article contains speculative content, opinions, and assumptions about the Walmart Health center that are not confirmed facts. The...
Rising levels of obesity have become a global health issue, with an estimated 2.8 million people dying each year...
In the evolving field of clinical trials, Risk-Based Quality Management (RBQM) emerges as a cornerstone for enhancing trial efficiency...
In a pioneering initiative, the Food and Drug Administration (FDA) has laid out a comprehensive discussion paper focusing on...
In silico methodologies have transformed the landscape of drug development, providing a virtual platform to predict and optimize drug...
The continent of Africa stands at a fascinating juncture in clinical trials, presenting a blend of untapped potential and...
Informed consent is not just a procedural formality but a basis of ethical practice, ensuring that participants fully understand...
The advent of sensor-based Digital Health Technologies (sDHTs) is transforming the landscape of clinical research and patient care. I...